135 results on '"Salles, Jean Pierre"'
Search Results
2. Diagnostic yield of bone fragility gene panel sequencing in children and young adults referred for idiopathic primary osteoporosis at a single regional reference centre
3. Growth hormone treatment improves final height in children with X-linked hypophosphatemia
4. Orofacial Features, Oral Health-Related Quality of Life, and Exposure to Bullying in Osteogenesis Imperfecta: A Cross-Sectional Study.
5. From Classical to Alternative Pathways of 2-Arachidonoylglycerol Synthesis: AlterAGs at the Crossroad of Endocannabinoid and Lysophospholipid Signaling.
6. Low bone mass in Noonan syndrome children correlates with decreased muscle mass and low IGF-1 levels
7. Biochemical assessment of phosphate homeostasis
8. X-linked hypophosphatemia and burosumab: Practical clinical points from the French experience
9. SNORD116 and growth hormone therapy impact IGFBP7 in Prader–Willi syndrome
10. A standard set of outcome measures for the comprehensive assessment of osteogenesis imperfecta
11. Patients with PWS and related syndromes display differentially methylated regions involved in neurodevelopmental and nutritional trajectory
12. Is ghrelin a biomarker of early-onset scoliosis in children with Prader–Willi syndrome?
13. Adherence to multidomain interventions for dementia prevention: Data from the FINGER and MAPT trials
14. Red blood cell membrane omega-3 fatty acid levels and physical performance: Cross-sectional data from the MAPT study
15. Two-year recombinant human growth hormone (rhGH) treatment is more effective in pre-pubertal compared to pubertal short children with X-linked hypophosphatemic rickets (XLHR)
16. Adult height improved over decades in patients with X-linked hypophosphatemia: a cohort study.
17. Growth Hormone Dose Modulation and Final Height in Short Children Born Small for Gestational Age: French Real-Life Data.
18. Bone metabolism during pregnancy
19. Deficiency in prohormone convertase PC1 impairs prohormone processing in Prader-Willi syndrome
20. LEOPARD syndrome-associated SHP2 mutation confers leanness and protection from diet-induced obesity
21. Obesity, Overweight, and Pituitary Stalk Interruption Syndrome in Children and Young Adults.
22. Noonan syndrome-causing SHP2 mutants inhibit insulin-like growth factor 1 release via growth hormone-induced ERK hyperactivation, which contributes to short stature
23. LB-048 - SAFETY, IMMUNE RESPONSE AND PRELIMINARY EFFICACY OF PPV-06 ACTIVE IMMUNOTHERAPY, A VACCINE FOR INFLAMMATORY KNEE OSTEOARTHRITIS: A PHASE 1, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, DOSE ESCALATION STUDY.
24. The role of cell surface markers and enamel matrix derivatives on human periodontal ligament mesenchymal progenitor responses in vitro
25. Absence of the lysophosphatidic acid receptor LPA1 results in abnormal bone development and decreased bone mass
26. Physical Activity and Amyloid-β Brain Levels in Elderly Adults with Intact Cognition and Mild Cognitive Impairment
27. High-resolution solid state NMR experiments for the characterization of calcium phosphate biomaterials and biominerals
28. Hypophosphatasia may lead to bone fragility: don’t miss it
29. Detection of the A189G mtDNA heteroplasmic mutation in relation to age in modern and ancient bones
30. Leprot and Leprotl1 cooperatively decrease hepatic growth hormone action in mice
31. WNT11, a new gene associated with early onset osteoporosis, is required for osteoblastogenesis.
32. Human dental follicle cells acquire cementoblast features under stimulation by BMP-2/-7 and enamel matrix derivatives (EMD) in vitro
33. Infigratinib in children with achondroplasia: the PROPEL and PROPEL 2 studies.
34. Elevated Insulin-Like Growth Factor-I Values in Children with Prader-Willi Syndrome Compared with Growth Hormone (GH) Deficiency Children over Two Years of GH Treatment
35. Hyperghrelinemia Precedes Obesity in Prader-Willi Syndrome
36. Detection and Quantification of the Age-Related Point Mutation A189G in the Human Mitochondrial DNA
37. Production of Lysophosphatidic Acid in Blister Fluid: Involvement of a Lysophospholipase D Activity
38. Increased platelet sodium-proton exchange rates in insulin-dependent (type 1) diabetic patients with nephropathy and hypertension
39. SHP2 drives inflammation-triggered insulin resistance by reshaping tissue macrophage populations.
40. Hypophosphatasia: A Case of Two Patients With Spinal Cord Compression From Increase in Ligamentous Ossifications During Treatment.
41. Dual effect of lysophosphatidic acid on proliferation of glomerular mesangial cells
42. Reservoir cells no longer detectable after a heterologous SHIV challenge with the synthetic HIV-1 Tat Oyi vaccine
43. Demographic Characteristics, Risk Factors, and Presenting Features of Children with Symptomatic Nutritional Rickets: A French Series.
44. Hypophosphatasia: Biological and Clinical Aspects, Avenues for Therapy.
45. Noonan syndrome males display Sertoli cell-specific primary testicular insufficiency.
46. Noonan syndrome-causing SHP2 mutants impair ERK-dependent chondrocyte differentiation during endochondral bone growth.
47. Early postnatal soluble FGFR3 therapy prevents the atypical development of obesity in achondroplasia.
48. Induced pluripotent stem cells (iPSC) created from skin fibroblasts of patients with Prader-Willi syndrome (PWS) retain the molecular signature of PWS.
49. Possible Role of Adipose Tissue and the Endocannabinoid System in Coronavirus Disease 2019 Pathogenesis: Can Rimonabant Return?
50. Fasting total ghrelin levels are increased in patients with adolescent idiopathic scoliosis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.